Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 235 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
Patents for C07D 235 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings (15,325)
10/2005
10/19/2005CN1683338A Process for preparing N-methyl quinoline codide compounds by ester reaction solvent
10/18/2005US6956050 Imidazole compounds as anti-inflammatory and analgesic agents
10/13/2005WO2005095343A1 Dpp-iv inhibitors
10/13/2005WO2005095338A1 Alkoxyphenylpropanoic acid derivatives
10/13/2005WO2005095327A1 Aniline derivatives
10/13/2005WO2005094805A1 Imine derivative and amide derivative
10/13/2005US20050228033 Voltage-gated sodium channel (VGSC) and prostate voltage sodium channel (PVSC) inhibitors for treating diseases characterized by overabundant or hyperactive VGSC/PVSC's; phenytoin derivatives; use as sodium channel blockers, anti-cancer agents; can be used to limit or prevent PSA growth and metastasis
10/13/2005US20050228022 blocking voltage-sensitive sodium channels of neurons in a mammal comprising administering 1-benzyl-2-imino-3-(2-hydroxy-3-phenoxypropyl)benzimidazole; analgesics; neuroprotectants; anticonvulsants
10/13/2005US20050228015 Substituted heteroaryl- and phenylsulfamoyl compounds
10/13/2005US20050227986 Vanilloid receptor ligands and their use in treatments
10/13/2005US20050227979 E.g., 1-[4-(1-Isopropyl-piperidin-4-yloxy)-benzyl]-piperidine and 1-[4-(1-Isopropyl-piperidin-4-yloxy)-benzyl]-azepane; these compounds modulate the activity of the histamine receptor, specifically the H3 receptor, without the inherent problems associated with the presence of an imidazolyl moiety
10/13/2005US20050227967 Treatment of T-helper cell type 2-mediated immune diseases by retinoid antagonists
10/13/2005US20050227963 Antiinflammatory agents
10/13/2005US20050227299 Fluorescent dyes (AIDA) for solid phase and solution phase screening
10/13/2005US20050225235 Materials for injecting or transporting holes and organic electroluminescence devices using the same
10/13/2005DE102004013528A1 New aza-heterocyclic spiro-cyclopropyl compounds, useful as pesticides, e.g. insecticides, acaricides, nematocides, ectoparasiticides and antifouling agents
10/13/2005CA2558446A1 Dpp-iv inhibitors
10/12/2005EP1584620A1 Process for preparing substituted benzimidazole compounds
10/12/2005EP1206466B1 Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
10/12/2005EP1202986B1 Amine and amide derivatives as ligands for the neuropeptide y y5 receptor useful in the treatment of obesity and other disorders
10/12/2005CN1681804A Sulphonamide derivatives and their use as TACE inhibitors
10/12/2005CN1681763A Chemical compounds
10/12/2005CN1680338A Cell adhesion-inhibiting antiinflammatory and immune-suppressive compounds
10/12/2005CN1222511C I-aryl-or-I-alkylsulfonyl-heterocyclylbenzazoles as 5-hydroxytryptamine-b ligands
10/12/2005CN1222374C Extrusion die
10/11/2005US6953857 Oxybenzamide derivatives useful for inhibiting factor Xa or viia
10/06/2005WO2005092899A1 Inhibitors of histone deacetylase
10/06/2005WO2005092866A1 New derivatives of 4, 5, 6, 7-tetrabromobenzimidazole and method of their preparation
10/06/2005WO2005092845A1 Substituted heteroaryl- and phenylsulfamoyl compounds
10/06/2005WO2005092316A1 Novel pharmaceutical compositions comprising agonists of the thyroid receptor
10/06/2005WO2005092066A2 Imidazole compounds
10/06/2005WO2005091752A2 Acrylonitrile derivatives for inflammation and immune-related uses
10/06/2005WO2005042559A3 Capture and release based isotope tagged peptides and methods for using the same
10/06/2005US20050222203 Nitrogen heterocycle biaryls for osteoporosis and other diseases
10/06/2005US20050222161 Antagonists to melanin-concentrating hormone receptor comprising benzimidazole derivative as active ingredient
10/06/2005US20050222148 Phenylaminopropanol derivatives and methods of their use
10/06/2005US20050222146 N-substituted-n-sulfonylaminocyclopropane compounds and pharmaceutical use thereof
10/06/2005DE10361794B3 Optisch aktive heteroaromatische ß-Hydroxy-Ester und Verfahren zu deren Herstellung sowie deren Verwendung als Zwischenprodukte bei der Epothilon-Totalsynthese Optically active heteroaromatic beta-hydroxy ester, and processes for their preparation and their use as intermediates in the total synthesis of epothilone-
10/06/2005CA2560896A1 Imidazole compounds
10/06/2005CA2560895A1 Acrylonitrile derivatives for inflammation and immune-related uses
10/06/2005CA2560526A1 Novel pharmaceutical compositions comprising agonists of the thyroid receptor
10/06/2005CA2559733A1 Inhibitors of histone deacetylase
10/06/2005CA2559035A1 Substituted heteroaryl- and phenylsulfamoyl compounds
10/05/2005EP1581527A2 Thrombopoietin mimetics
10/05/2005EP1581521A1 Fused heterocyclic derivatives as ppar modulators
10/05/2005EP1581491A1 Indole derivatives as ppar modulators
10/05/2005EP1581309A2 Kinase modulators
10/05/2005CN1221535C Spiroimidazolidine derivatives, their prepn. their use and pharmaceutical preparation comprising them
10/05/2005CN1221529C Substituted N-[(aminoiminomethyl or aminomethyl) phenyl] propyl amides
10/04/2005US6951849 Psychological disorders; central nervous system disorders; schizophrenia
10/04/2005US6951848 Functionalized heterocycles as modulators of chemokine receptor function and methods of use therefor
09/2005
09/29/2005WO2005090512A1 New materials for injecting or transporting holes and organic electroluminescence devices using the same
09/29/2005WO2005090292A1 Derivatives of heteroaryl-alkylcarbamates, preparation method thereof and use of same as faah enzyme inhibitors
09/29/2005US20050215794 Group IB compounds used as condensation, amination, amidation or arylation catalysts; catalysis; efficiency; forming a carbon-carbon bond between a reactant comprising a nucleophilic carbon atom, e.g., enolate or malonate anion, and activated carbon of an aryl, heteroaryl, or vinyl halide or sulfonate
09/29/2005US20050215645 Naphthalene-1-(sulfonamide or carboxamide) derivatives; e.g. N-Benzyl-5-{[(4-methylphenyl)sulfonyl]oxy}naphthalene-1-sulfonamide; protein kinase inhibitors sensitize cancer cells to radiotherapy or anticancer agents; side effect reduction
09/29/2005US20050215587 An aromatic alkylamino compound containing a lipophilic group useful as antithrombotic agent and for use in the treatment of mast cell mediated diseases such as asthma and other allergic and inflammatory conditions
09/29/2005US20050215573 Novel inhibitors of glutaminyl cyclase
09/29/2005CA2559310A1 7h-8,9-dihydro-pyrano (2,3-c) imidazo (1,2a) pyridine derivatives and their use as gastric acid secretion inhibitors
09/29/2005CA2554609A1 Derivatives of heteroaryl-alkylcarbamates, preparation method thereof and use of same as faah enzyme inhibitors
09/28/2005CN1675185A Therapeutic molecules and methods-1
09/28/2005CN1675170A Acylated arylcycloalkylamines and their use as pharmaceuticals
09/28/2005CN1675154A Napththalene derivatives which inhibit the cytokine or biological activity of macrophage migration inhibitory factor (MIF)
09/27/2005US6949556 For producing drugs used for therapy of cardiovascular diseases, stable or unstable angina pectoris, coronary heart disease, Prinzmetal angina, acute coronary syndrome, heart failure, myocardial infarction, stroke, thrombosis
09/27/2005CA2173876C Alkoxy alkyl carbamates from imidazo(1,2-a)pyridines
09/22/2005US20050209338 Phenethanolamine derivatives for treatment of respiratory diseases
09/22/2005US20050209284 Tec kinase inhibitors
09/22/2005US20050209282 Inhibitors of voltage-gated sodium channels; acute, chronic, neuropathic, or inflammatory pain such as femur cancer pain; non-malignant chronic bone pain; rheumatoid arthritis; osteoarthritis; spinal stenosis; neuropathic low back pain; neuropathic low back pain; myofascial pain syndrome; fibromyalgia
09/21/2005EP1575925A1 Novel carboxamides, the production and use thereof as medicaments
09/21/2005EP1575924A1 4-substituted benzimidazoles and their use as inhibitors of gastric secretion
09/21/2005EP1137640B1 Cyclic hydrazine derivatives as tnf-alpha inhibitors
09/21/2005CN1671672A Aryl substituted benzimidazoles and their use as sodium channel blockers
09/21/2005CN1671377A 1H-1, 2, 4-triazole-3-carboxamide derivatives as cannabinoid-CB receptor ligands
09/21/2005CN1219510C Benzimidazole derivatives as modulators of IgE
09/15/2005WO2005068433A9 Benzimidazole derivatives
09/15/2005WO2005049589A3 Heterocyclic compounds for the treatment of hyperlipidemia, diabetes, obesity and similar diseases
09/15/2005US20050203158 Substituted benzimidazole compounds
09/15/2005US20050203146 P2Y1 Purinoreceptor; thromboembolic disorders; compounds are 2-((hetero)arylamino) benzimidazoles, benzoxazoles or benzothiazoles such as [2-(2-tert-butyl-phenoxy)-pyridin-3-yl]-(6-methyl-1H-benzoimidazol-2-yl)-amine
09/15/2005US20050203141 Polymorphic forms 2 and 3 of bilastin is transformed into polymorph 1, which is very stable and is not transformed into any of the other polymorphs 2 and 3; allergic reactions, pathological processes mediated by histamine
09/15/2005US20050203108 Glucagon antagonists/inverse agonists
09/15/2005US20050203094 Thromboembolic disorders; anticoagulants; e.g. 2-[5'-fluoro-2,2'-dihydroxy-5-(2-oxo-tetrahydro-furan-3-yl)-biphenyl-3-yl]-1H-benzoimidazole-5-carboxamidine
09/15/2005US20050203078 Inhibitors of factor Xa or related serine proteases; thrombosis; benzamide derivatives with benzimidazole, indole or imidazo(1,2-a)pyridine rings; e.g. 4-(azepan-2-on-1-yl)-N-[(1R)-1-(5-chloro-1H-benzimidazol-2-yl)-2-methoxy-ethyl]-3-methyl-benzamide
09/15/2005CA2556386A1 Isothiourea derivatives
09/14/2005EP1572129A2 Amidine derivatives for treating amyloidosis
09/14/2005EP1210335B1 Aminocarbonyl-substituted benzimidazole derivatives, method for producing same and the use thereof as medicaments
09/14/2005CN1668593A Heterocyclically substituted benzoylureas, process for their preparation and their use as pharmaceuticals
09/13/2005US6943149 Thrombosis, restenosis, hypertension, heart failure, arrhy-thmia, inflammation, angina, stroke, atherosclerosis, cancer, ischemic conditions, angiogenesis related disorders, neuro-degenerative disorders
09/09/2005WO2005082895A1 Novel carboxamides for use as xa inhibitors
09/09/2005WO2005082894A1 Cell targeting conjugates
09/09/2005WO2005082871A2 Guanidine compounds, and use thereof as binding partners for 5-ht5 receptors
09/09/2005WO2005082862A2 Benzimidazolyl derivatives as kinase inhibitors
09/09/2005WO2005081687A2 Human hinge core mimetibodies, compositions, methods and uses
09/09/2005WO2005018568A3 Inhibitors of cathepsin s
09/09/2005CA2599304A1 Cell targeting conjugates
09/09/2005CA2557398A1 Benzimidazolyl derivatives as kinase inhibitors
09/08/2005US20050197375 Use of benzimidazole analogs in the treatment of cell proliferation
09/08/2005US20050197362 Preventives/remedies for urinary disturbance
09/08/2005US20050197331 Novel anti-inflammatory and analgesic heterocyclic amidines that inhibit nitrogen oxide (NO) production
09/07/2005EP1571142A1 Novel anti-inflammatory and analgesic heterocyclic amidines that inhibit nitrogen oxide (NO) production
09/07/2005EP1569919A2 Non-nucleoside reverse transcriptase inhibitors
09/07/2005EP1569916A1 Substituted aralkyl derivatives
1 ... 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 ... 154